We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Healthcare 15.8%
3 Financials 11.35%
4 Consumer Discretionary 9.79%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OFS icon
1251
OFS Capital
OFS
$46.2M
$108K ﹤0.01%
10,200
– –
AQUA
1252
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$106K ﹤0.01%
+11,032
New +$127K
BLCM
1253
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$104K ﹤0.01%
3,570
– –
NE
1254
DELISTED
Noble Corporation
NE
$99K ﹤0.01%
37,800
– –
NBR icon
1255
Nabors Industries
NBR
$1.17B
$97K ﹤0.01%
968
– –
GSIT icon
1256
GSI Technology
GSIT
$201M
$95K ﹤0.01%
18,400
– –
DF
1257
DELISTED
Dean Foods Company
DF
$94K ﹤0.01%
24,700
-6,200
-20% -$37.5K
SBS icon
1258
Sabesp
SBS
$18.4B
$92K ﹤0.01%
58,470
– –
QEP
1259
DELISTED
QEP RESOURCES, INC.
QEP
$89K ﹤0.01%
15,800
– –
ACH
1260
Accendra Health
ACH
$254M
$85K ﹤0.01%
13,500
-5,600
-29% -$58.1K
AUY
1261
DELISTED
Yamana Gold, Inc.
AUY
$77K ﹤0.01%
32,787
– –
IO
1262
DELISTED
ION Geophysical Corporation
IO
$70K ﹤0.01%
13,500
-8,000
-37% -$81.3K
TNAV
1263
DELISTED
Telenav Inc.
TNAV
$66K ﹤0.01%
+16,327
New +$70.3K
VSI
1264
DELISTED
Vitamin Shoppe Inc.
VSI
$62K ﹤0.01%
+13,100
New +$98.4K
PDLI
1265
DELISTED
PDL BioPharma, Inc.
PDLI
$60K ﹤0.01%
20,700
– –
HBIO icon
1266
Harvard Bioscience
HBIO
$27.6M
$43K ﹤0.01%
+1,367
New +$53.9K
UTSI icon
1267
UTStarcom
UTSI
$22M
$41K ﹤0.01%
3,800
– –
PXLW icon
1268
Pixelworks
PXLW
$37.2M
$38K ﹤0.01%
1,102
-1,726
-61% -$80.3K
AVP
1269
DELISTED
Avon Products, Inc.
AVP
$33K ﹤0.01%
21,600
– –
PFNX
1270
DELISTED
Pfenex Inc.
PFNX
$32K ﹤0.01%
+10,000
New +$42.8K
CTIC
1271
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$20K ﹤0.01%
27,400
-34,600
-56% -$56.8K
AA icon
1272
Alcoa
AA
$11.3B
– –
-30,000
Closed -$1.21M
ADEA icon
1273
Adeia
ADEA
$2.55B
– –
-86,940
Closed -$342K
AMKR icon
1274
Amkor Technology
AMKR
$10.6B
– –
-676,000
Closed -$5M
AOSL icon
1275
Alpha and Omega Semiconductor
AOSL
$829M
– –
-13,100
Closed -$152K
49 50
51
52 53

Similar funds

PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.